Telesair, Inc. Obtains Health Canada License for Bonhawa® High Flow Oxygen Therapy Device – Targets Expansion with Novus Medical, Inc.
- jameszhou8
- May 19
- 2 min read
IRVINE, CA – Telesair, Inc., an emerging medical technology company focused on respiratory
care, announces it has obtained Health Canada licensing entering its next phase of North
American expansion. This is a result of Telesair’s agile and coordinated internal effort. While
leveraging MDSAP compliance, Telesair’s deep institutional expertise in navigating global
regulatory environments allowed for efficient market licensing.
Looking forward, Telesair targets market expansion in partnership with Novus Medical, an
innovative and customer centric distributor of respiratory, diagnostic and critical care medical
devices and supplies. Hospitals and providers across the Canadian Health system will now be
able to access the Bonhawa® High Flow Oxygen Therapy device to set new standard of
respiratory care.
The Bonhawa® HFOT system is Telesair's flagship product in the respiratory market, offering an
innovative solution designed to deliver comfortable, effective high-flow respiratory support to
critically ill patients.
"Telesair is excited to be partnering with Novus Medical as we expand our presence outside of
the US!” said Matt Margolies, President and Chief Operating Officer of Telesair. “Novus is
the perfect business partner for us as they exhibit the same customer and patient focus that is
our mission!”
Novus Medical strives to lead the industry in customer support through service, education and
knowledge. Novus continues to look for new products that will also improve patient care,
operational efficiency, and reduction on burden to the healthcare system.
"Adding the Telesair Bonhawa® to our lineup shows our commitment to bringing new respiratory
technology to Canada," said Murray Beaton, President and CEO of Novus Medical. "For over
a decade, there haven't been many options for high-flow oxygen therapy in the Canadian
market. The Bonhawa® HFOT finally gives Canadian RTs a choice with another high-quality
device that also helps manage costs."
Telesair is excited to continue its commercial expansion of new respiratory technologies and
make a positive impact on global patient care.
About Telesair, Inc. Telesair, Inc., based in Irvine, California, is dedicated to developing
innovative solutions that enhance respiratory care, improve patient quality of life, and
transform healthcare delivery. Leveraging cutting-edge technology and a patient-centric
approach, the company addresses unmet needs in the healthcare market. Visit
www.telesair.com for more information.
About Novus Medical, Inc. Novus Medical is a premier Canadian distributor dedicated to
providing advanced technology across the continuum of care. With a specialized focus on
Respiratory Therapy, Infant Care, and Neuro-Diagnostics, we have spent over 40 years bridging
the gap between global medical innovation and the Canadian healthcare landscape. Our
comprehensive portfolio supports a wide array of clinical needs.
What distinguishes Novus Medical in a landscape of large, impersonal corporations is our
commitment to specialized clinical expertise, personalized customer service and a responsive
service department. We believe that medical device distribution requires more than just
logistical efficiency; it requires a deep technical and clinical understanding of the tools that
save and improve lives. At Novus, we are large enough to serve, yet small enough to care. Visit
novusmedical.ca for more information.
Telesair Media Contact:
Erik Lobben, Product Management